FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

773265003: Lusutrombopag (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3722803016 Lusutrombopag en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3722804010 Lusutrombopag (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3722803016 Lusutrombopag en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3722804010 Lusutrombopag (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5534681000241119 lusutrombopag fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5534681000241119 lusutrombopag fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lusutrombopag Is a Thrombopoietin receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)
Lusutrombopag Is a Cinnamic acid (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Lusutrombopag Has disposition Thrombopoietin receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Lusutrombopag-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lusutrombopag Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing lusutrombopag in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lusutrombopag Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only lusutrombopag (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lusutrombopag Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only lusutrombopag in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lusutrombopag Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start